![]() ChemomAb ChemomAb is a clinical stage biopharmaceutical company which develops therapeutic antibodies for the treatment of autoimmune and inflammatory diseases. | ![]() Inozyme Inozyme is a biotechnology company that develops medicines to treat rare diseases of calcification. | ||
Founding Date | Founding Date 2009 | Founding Date 2010 | Founding Date 2016 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Berlin, DE HQ | Locations Tel Aviv-Yafo, IL HQ | Locations Boston, US HQ Boston, US Boston, US |
Employees | Employees 14 | Employees N/A | Employees 653% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 28.1 m | Valuation ($) 310 m |
Financial | |||
Net income | Net income N/A | Net income ($9m) (FY, 2025) | Net income ($102m) (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised $ 10.6m | Total funding raised $ 15m | Total funding raised $ 116m |

ChemomAb is a clinical stage biopharmaceutical company which develops therapeutic antibodies for the treatment of autoimmune and inflammatory diseases.
View company
Inozyme is a biotechnology company that develops medicines to treat rare diseases of calcification.
View company